Skip to main content

Cancer

academics

 

Clinical research courses

  • Vacancy for B.Pharm/M.Pharm in Drug resistant Breast Cancer project at NIN

    NIN has attained global recognition for its pioneering studies on various aspects of nutrition research, with special reference to protein energy malnutrition (PEM). Institute’s activities are broad-based, encompassing the whole area of food and nutrition. The Institute has achieved close integration in its research activities between the laboratory, the clinic and the community.

  • Career for M.Pharm as Project Fellow at Central University of Rajasthan

    The Central University of Rajasthan has been established by an Act of Parliament (Act No. 25 of 2009, The Gazette of India, No. 27, published on 20th March, 2009 as a new Central University, and is fully funded by the Government of India. The President of India, His Excellency Shri Pranab Mukherjee, is the Visitor of the Central University of Rajasthan.

  • Consumption of tea, particularly black and green, greatly reduces the risk of cancer in human beings due to the presence of anti-oxidant agents, according to a researcher with a US university.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • The U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer. Portrazza is marketed by Eli Lilly and Company, based in Indianapolis, Indiana.

  • Researchers have identified a drug that works to limit the spread of glioblastoma, the most common primary tumour of the brain and central nervous system which is also regarded as one of the most aggressive of all cancers.

Subscribe to Cancer